![Frontiers | Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies Frontiers | Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies](https://www.frontiersin.org/files/Articles/334260/fphys-09-00105-HTML/image_m/fphys-09-00105-g001.jpg)
Frontiers | Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies
![Molecules | Free Full-Text | Transcription Factors as Therapeutic Targets in Chronic Kidney Disease | HTML Molecules | Free Full-Text | Transcription Factors as Therapeutic Targets in Chronic Kidney Disease | HTML](https://www.mdpi.com/molecules/molecules-23-01123/article_deploy/html/images/molecules-23-01123-g001-550.jpg)
Molecules | Free Full-Text | Transcription Factors as Therapeutic Targets in Chronic Kidney Disease | HTML
![Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/23/10/1663/F6.large.jpg?width=800&height=600&carousel=1)
Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology
![Antioxidants | Free Full-Text | Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling | HTML Antioxidants | Free Full-Text | Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling | HTML](https://www.mdpi.com/antioxidants/antioxidants-10-00258/article_deploy/html/images/antioxidants-10-00258-g001.png)
Antioxidants | Free Full-Text | Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling | HTML
![Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure | Journal of Pharmacology and Experimental Therapeutics Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/371/3/642/F2.large.jpg)
Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure | Journal of Pharmacology and Experimental Therapeutics
![Cancers | Free Full-Text | Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer | HTML Cancers | Free Full-Text | Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer | HTML](https://www.mdpi.com/cancers/cancers-10-00352/article_deploy/html/images/cancers-10-00352-g001.png)
Cancers | Free Full-Text | Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer | HTML
![Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/23/10/1663/F4.large.jpg)
Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology
![Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2 - Kidney International Reports Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2 - Kidney International Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2ef9f074-31fb-407f-9505-bc9923575a35/gr3_lrg.jpg)
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2 - Kidney International Reports
![Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253819305034-fx1.jpg)
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect
![Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl - Journal of Cardiac Failure Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl - Journal of Cardiac Failure](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/82802f72-5a31-4616-b8d0-2ee9e94e0b69/gr1.jpg)